Ohad Oren, MD

Dr. Oren has received multiple awards recognizing his contributions to research and clinical care, including the American Society of Hematology Abstract Achievement Award, the American Heart Association “Best of QCOR” oral abstract award, and the Conquer Cancer Merit Award. His work has also been highlighted at national meetings of the American College of Cardiology and the American Society of Clinical Oncology throughout the years.

2025 - Poster Award, ACC cardiovascular care of the cancer patient, February 2025 - American College of Cardiology

2024 - Nominated for ACC Legislative Conference, Washington, DC, September 2024 - American College of Cardiology

2023 - Top clinical case presentation - ACC

2020 - Conquer Cancer Merit Award - ASCO

2019 - Nominated for Annual Southeastern Fellows Research Skills and Training workshop - Duke University

2019 - Nominated for Hemostasis and Thrombosis Research Society (HTRS) Trainee Workshop - Duke University

2018 - Council on Cardiovascular Surgery and Anesthesia (CVSA) Resident Award - American Heart Association

2017 - Best of QCOR oral abstracts: health policy, cost and value - American Heart Association

2016 - ASH Abstract Achievement Award - American Society of Hematology

2011 - Nominated by Dean of Medical School for Excellence Exchange program between the Technion and Brown University - Technion – Israel Institute of Technology

2007 - Vivian Konigsberg Award for Excellence in Teaching - Technion – Israel Institute of Technology

See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.

As of 2025-09-26, Dr. Oren has reported no financial relationship with industry that is applicable to this listing.

In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.